Figure 1From: Near-infrared spectroscopy StO2 monitoring to assess the therapeutic effect of drotrecogin alfa (activated) on microcirculation in patients with severe sepsis or septic shockEvolution over time in treated and control patients. *p < 0.05 compared with T0; §p < 0.05 compared with control patients.Back to article page